Researchers & Healthcare Professionals

The Pediatric Treatment Approach to Adult Acute Lymphocytic Leukemia

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: November 19, 2009
Credit Available Until: July 7, 2011
Target Audience: Oncology nurses and other healthcare professionals
Access: Virtual Lecture

Activity Purpose

This activity is designed to educate oncology nurses about the pediatric treatment approach to adult acute lymphocytic leukemia (ALL).

Educational Objectives

At the conclusion of the activity, the participant should be better able to:

  • Examine data from clinical trials using pediatric acute lymphocytic leukemia (ALL) treatment protocols in adult ALL patients
  • Describe therapeutic options for ALL
  • Apply knowledge of administration and drug interactions to ALL treatments
  • Develop a plan for side effect management that maximizes patient safety, treatment adherence and quality of life


Barton A. Kamen, M.D., Ph.D.
Chief Medical Officer
The Leukemia & Lymphoma Society
White Plains, NY
Professor of Pediatrics and Pharmacology
The Cancer Institute of New Jersey
UMDNJ - Robert Wood Johnson Medical School
New Brunswick, NJ

Katherine A. Breitenbach, B.A., R.N.
Clinical Research Nurse
Section of Hematology/Oncology
University of Chicago Medical Center
Chicago, Illinois

Sponsors and Supporters

This continuing education program is supported by a grant from Enzon Pharmaceuticals, Inc.

last updated on Friday, September 09, 2011



A free resource provided by the National Institutes of Health - access more than 20 million biomedical literature citations.

Learn More